Proof of concept for a novel IoT system that offers a cost-effective and productivity enhancing learning support system for children with special education needs

新型物联网系统的概念验证,该系统为有特殊教育需求的儿童提供具有成本效益且可提高生产力的学习支持系统

基本信息

  • 批准号:
    31510
  • 负责人:
  • 金额:
    $ 14.42万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Collaborative R&D
  • 财政年份:
    2019
  • 资助国家:
    英国
  • 起止时间:
    2019 至 无数据
  • 项目状态:
    已结题

项目摘要

This proof of concept feasibility project, underpinned by participatory design, will research, design and develop an OliTool prototype system for user-testing with special needs children in primary school.Incorporating stakeholder feedback from the outset, OliTool will be an innovative adaptive learning IoT system comprising a sensory tangible user interface and a companion app for children with SEN challenges, particularly ASD, ADHD and/or anxiety. It aims to meet the need for a cost-effective SEN support tool with features that help:* Children learn to regulate sensory needs, and understand and communicate behaviours and emotions in real-time to adult supervisors;* Supervising adults gather valuable data for assessments and evaluations.Ogenblik Ltd are the developers of OliTool, a next generation interactive tangible user interface connected to a personalised app. The current prototype was trialled successfully on adults with anxiety at Exeter University in a six-week trial. OliTool draws on behaviour change practices and cognitive behavioural therapy to help identify troublesome behaviour patterns and triggers and support behaviour change. The Exeter trial demonstrated proof of concept and offered important insights into user needs and preferences and barriers to adoption. Additional feedback from psychologists, health professionals (including leading clinicians at Tavistock and Portman NHS Foundation Trust), educators and parents suggested that developing OliTool for children presented a strong business opportunity. The concept of OliTool for children was further tested on a cohort of Year 4 children to positive results at a West London primary school. The vital next step for Ogenblik, and the focus of this application, is to redesign OliTool for SEN children with a particular focus on attention and hyperactivity disorders, autism and anxiety.Current provision for SEN children is largely based on direct interventions by SEN specialists, teachers and other experts employing primarily analogue SEN resources. Robotics, virtual reality and gamification approaches, such as Milo, Floreotech and MyCognition, are being explored, but few digital resources provide an engaging haptically enabled physical interface.Experience with EdTech and eHealth has shown that engaging technology can engender cost efficiencies. For example, research has shown that internet CBT is just as effective as in-person CBT while reducing provision costs by up to 40%. Text-based CBT has also been demonstrated as efficient and cost-effective. OliTool, a non-screen based discrete tangible user interface and personalisable app, leveraging evidence-based SEN support techniques, offers a novel cost-effective tool for assessment, intervention and evaluation for SEN children. Crucially, it provides educators innovative methods to improve SEN provision.
这个以参与式设计为基础的概念可行性验证项目将研究、设计和开发一个OliTool原型系统,供小学有特殊需要的儿童进行用户测试。OliTool从一开始就整合了利益相关者的反馈,将成为一个创新的自适应学习物联网系统,包括一个感官有形的用户界面和一个配套的应用程序,适用于有特殊教育障碍的儿童,特别是ASD、ADHD和/或焦虑症的儿童。它旨在满足对具有成本效益的特殊教育支持工具的需求,并具有以下功能:*儿童学会调节感官需求,理解行为和情绪,并实时与成人主管沟通;*监督成年人为评估和评估收集有价值的数据。Ogenblik有限公司是OliTool的开发商,OliTool是一种连接到个性化应用程序的下一代交互式有形用户界面。目前的原型在埃克塞特大学进行了为期六周的试验,成功地在患有焦虑症的成年人身上进行了试验。OliTool利用行为改变实践和认知行为疗法来帮助识别麻烦的行为模式和触发因素,并支持行为改变。埃克塞特的试验证明了概念的正确性,并提供了对用户需求、偏好和采用障碍的重要见解。心理学家、健康专家(包括塔维斯托克和波特曼NHS基金会信托基金的主要临床医生)、教育工作者和家长的反馈表明,为儿童开发OliTool提供了一个强大的商业机会。在西伦敦的一所小学,对一群四年级学生进一步测试了儿童OliTool的概念,取得了积极的结果。Ogenblik的下一个关键步骤,也是这个应用程序的重点,是为SEN儿童重新设计OliTool,特别关注注意力和多动障碍,自闭症和焦虑。目前为特殊教育背景儿童提供的服务主要基于特殊教育背景专家、教师和其他专家的直接干预,主要采用模拟的特殊教育背景资源。机器人技术、虚拟现实和游戏化方法(如Milo、Floreotech和MyCognition)正在被探索,但很少有数字资源提供引人入胜的触觉物理界面。教育技术和电子健康的经验表明,采用技术可以提高成本效率。例如,研究表明,网络CBT与面对面CBT一样有效,同时可减少高达40%的供应成本。基于文本的CBT也被证明是有效和经济的。OliTool是一个非基于屏幕的离散有形用户界面和个性化应用程序,利用基于证据的SEN支持技术,为SEN儿童的评估、干预和评估提供了一种新颖的经济有效的工具。至关重要的是,它为教育工作者提供了创新的方法来改善特殊教育教学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Studentship

相似海外基金

A Phase I Proof-of-Concept Study of CBL0137 Combined with Ipilimumab and Nivolumab Therapy in Locally Advanced or Metastatic Melanoma
CBL0137 联合 Ipilimumab 和 Nivolumab 治疗局部晚期或转移性黑色素瘤的 I 期概念验证研究
  • 批准号:
    10722873
  • 财政年份:
    2023
  • 资助金额:
    $ 14.42万
  • 项目类别:
Demonstrating miniaturized production of a KOR PET tracer as a proof-of-concept for low-cost distribution of nascent PET neurotracers
展示 KOR PET 示踪剂的小型化生产,作为新兴 PET 神经示踪剂低成本分销的概念验证
  • 批准号:
    10822523
  • 财政年份:
    2023
  • 资助金额:
    $ 14.42万
  • 项目类别:
Metformin as a novel, mechanistic treatment of fibromyalgia; a proof of concept RCT
二甲双胍作为纤维肌痛的新型机械治疗方法;
  • 批准号:
    10655834
  • 财政年份:
    2023
  • 资助金额:
    $ 14.42万
  • 项目类别:
Proof of concept study of a highly novel food fortification to boost exercise performance in younger and older adults
一种高度新颖的食品强化剂的概念验证研究,可提高年轻人和老年人的运动表现
  • 批准号:
    10073883
  • 财政年份:
    2023
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Collaborative R&D
Proof of concept evaluation of a novel breast cancer therapeutic
一种新型乳腺癌治疗方法的概念验证评估
  • 批准号:
    10026580
  • 财政年份:
    2022
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Collaborative R&D
Pathway to Equity: Feasibility and Proof of Concept of Meaning-Centered Psychotherapy for Chinese Patients with Advanced Cancer
通往公平之路:对中国晚期癌症患者进行以意义为中心的心理治疗的可行性和概念证明
  • 批准号:
    10512812
  • 财政年份:
    2022
  • 资助金额:
    $ 14.42万
  • 项目类别:
Development and Proof of Concept testing of a novel Intelligent Biobank Platform
新型智能生物样本库平台的开发和概念验证测试
  • 批准号:
    10028432
  • 财政年份:
    2022
  • 资助金额:
    $ 14.42万
  • 项目类别:
    Collaborative R&D
Pathway to Equity: Feasibility and Proof of Concept of Meaning-Centered Psychotherapy for Chinese Patients with Advanced Cancer
通往公平之路:对中国晚期癌症患者进行以意义为中心的心理治疗的可行性和概念证明
  • 批准号:
    10673022
  • 财政年份:
    2022
  • 资助金额:
    $ 14.42万
  • 项目类别:
Small molecule inhibitors of hyperphosphorylated tau aggregation in Alzheimer's disease: lead optimization, and proof of concept in a rodent model
阿尔茨海默病中过度磷酸化 tau 蛋白聚集的小分子抑制剂:先导化合物优化和啮齿动物模型中的概念验证
  • 批准号:
    10621755
  • 财政年份:
    2022
  • 资助金额:
    $ 14.42万
  • 项目类别:
The START trial: a proof-of-concept sedentary reduction program for prefrail older adults
START 试验:针对体弱老年人的概念验证减少久坐计划
  • 批准号:
    10429646
  • 财政年份:
    2022
  • 资助金额:
    $ 14.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了